Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Jul 14, 2022

BUY
$4.73 - $7.18 $4,730 - $7,180
1,000 New
1,000 $3,000
Q4 2021

Jan 21, 2022

SELL
$5.36 - $9.53 $5,360 - $9,530
-1,000 Closed
0 $0
Q3 2021

Oct 22, 2021

BUY
$8.21 - $10.53 $8,210 - $10,530
1,000 New
1,000 $9,000

Others Institutions Holding SLS

About SELLAS Life Sciences Group, Inc.


  • Ticker SLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,551,900
  • Market Cap $19.5M
  • Description
  • SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...
More about SLS
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.